Kristien Boelaert, MD, PhD

Professor of Endocrinology
UNIVERSITY OF BIRMINGHAM
Birmingham, United Kingdom

Disclosure information not submitted.

Presentation(s):

• SUN-328 - Phase 3 Randomized-Controlled Trials Evaluating Efficacy and Safety of Subcutaneous Efgartigimod PH20 using Pre-Filled Syringes in Patients with Graves' Disease Inadequately Controlled with Antithyroid Drugs: Trials in Progress

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT

• ORF41-04 - Levothyroxine Treatment in Women with High-Normal Thyrotropin, Thyroperoxidase Antibodies or Both, Prior to or during Early Pregnancy: An Individual Participant Data Meta-Analysis of 8 Randomised Trials

  Monday, June 15, 2026
  9:45 AM - 10:00 AM CT